Finally, recent works have demonstrated that blocking NLRP3 pathway in PC-3 cells and PCa-derived xenografts have a significant impact on tumor progression by disrupting cell proliferation, migration, and/or inducing apoptosis [98, 100, 101]. The gene discussed is NLRP3; the disease is neoplasm.